| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.2 | 6e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |